Stay updated on Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Sign up to get notified when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.

Latest updates to the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page
- Check6 days agoChange DetectedRemoved the term 'Non-alcoholic fatty liver disease' from the page's conditions/topics and deleted the related topic link to MedlinePlus Genetics.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 and a maintenance notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check20 days agoChange DetectedA funding-status notice was added at the top of the page, and the site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a Show glossary toggle and a new 'Last Update Submitted that Met QC Criteria' timestamp. Updated the footer to 'No FEAR Act data' capitalization and bumped the page revision to v3.4.0, replacing the previous 'Last Update Submitted that met QC Criteria' label.SummaryDifference0.2%

- Check42 days agoChange DetectedNAFLD is added as a related topic and MedlinePlus Genetics is listed as a related topic; the page revision is updated from v3.3.3 to v3.3.4.SummaryDifference0.2%

- Check49 days agoChange DetectedRemoved the NAFLD topic tag and the related MedlinePlus Genetics topic from the page's topics.SummaryDifference0.1%

Stay in the know with updates to Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.